Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net loss from continuing operations	$ (217,390)	$ (409,837)
Less: Income (Loss) from discontinued operations, net of tax	4,672	(80,708)
Net loss from continuing operations	(222,062)	(329,129)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	26,858	28,174
Gain on sale of assets	2	0
Stock-based compensation	39,451	42,540
Amortization of debt discount	1,918	1,844
Deferred income tax benefit	(485)	(1,150)
Change in fair value of warrant liabilities	0	1,701
Amortization of right-of-use assets	2,337	2,357
Other adjustments	480	1,571
Changes in operating assets and liabilities of business, net of acquisitions:
Accounts receivable, net	(18,123)	(9,846)
Prepaid expenses and other assets	(14,173)	(858)
Prepaid sports rights	(1,125)	(32,334)
Accounts payable	(7,545)	18,476
Accrued expenses and other liabilities	605	(9,415)
Deferred revenue	20,543	14,448
Lease liabilities	(1,669)	953
Net cash used in operating activities - continuing operations	(172,988)	(270,668)
Net cash used in operating activities - discontinued operations	(2,569)	(25,149)
Net cash used in operating activities	(175,557)	(295,817)
Cash flows from investing activities
Purchase of short-term investments	0	(100,000)
Purchases of property and equipment	(375)	(1,031)
Sale of property and equipment	11	0
Capitalization of internal use software	(12,875)	(3,519)
Purchase of intangible assets	(2,899)	0
Net cash used in investing activities - continuing operations	(16,138)	(104,550)
Net cash used in investing activities - discontinued operations	0	(6,277)
Net cash used in investing activities	(16,138)	(110,827)
Cash flows from financing activities
Proceeds from the issuance of common stock, net of offering costs	116,890	228,960
Redemption of non-controlling interest	(2,147)	0
Vested restricted stock units settled for cash	(125)	0
Proceeds from exercise of stock options	259	749
Proceeds from the exercise of warrants	0	5,000
Repayments of notes payable and long-term borrowings	(335)	(1,472)
Net cash provided by financing activities - continuing operations	114,542	233,237
Net cash provided by financing activities - discontinued operations	0	0
Net cash provided by financing activities	114,542	233,237
Net decrease in cash, cash equivalents and restricted cash	(77,153)	(173,407)
Cash, cash equivalents and restricted cash at beginning of period	343,226	376,080
Cash, cash equivalents and restricted cash at end of period	266,073	202,673
Supplemental disclosure of cash flows information:
Interest paid	13,120	13,469
Income taxes paid	190	0
Non-cash financing and investing activities:
Shares settled liability	5,536	994
Reclassification of the equity components of the 2026 Convertible Notes to liability upon adoption of ASU 2020-06	0	75,264
Cashless exercise of warrants	0	5,249
Accrued expenses - Issuance of common stock	6	292
Accounts payable - purchases property and equipment	403	0
Accounts payable - purchases of intangible assets	$ 693	$ 0